Multiple Myeloma Drug Has Heavier Burden for Obese Patients

medpage Today

NEW ORLEANS -- Obese patient treated for multiple myeloma with melphalan are more likely to suffer from severe oral mucositis than thinner patients, researchers said here.

In a multivariate analysis, for every additional 10 percentage points of body fat, there was a 0.65-point increase in the Oral Mucositis Assessment Score (OMA) among the patients studied (P=0.01), according to Dan Vogl, MD, of the University of Pennsylvania, and colleagues... Read More